摘要
Introduction: Hyponatremia is the commonest electrolyte disorder in hospitalized patients. There is a significant research gap in understanding why hyponatremia worsens patient outcomes and leads to cognitive impairment, particularly in chronic hyponatremia, in which cerebral edema is not observed. The aim of this study was to evaluate the impact of acute (<48 hours) and chronic (>2–3 days) hyponatremia on cerebral microvessels, focusing primarily on blood–brain barrier integrity, oxidative stress, and inflammation.
Methods: Male Wistar rats were made hyponatremic acutely (5–6 h; subcutaneous arginine vasopressin [AVP] or desmopressin [dDAVP] plus intraperitoneal water load, 11% body weight) or chronically (4 days; AVP or dDAVP from implanted ALZET osmotic minipumps plus liquid AIN-76 diet). Brain water content was assessed using the wet–dry method and BBB permeability with sodium fluorescein. Cerebral microvessel mRNA for iNOS, eNOS, claudin-5, occludin, IL-1β, and IL-6 was quantified by RT-PCR. Superoxide production in parenchymal arterioles was assessed by dihydroethidium staining and NO bioavailability by plasma nitrite chemiluminescence.
Results: Brain water content rose only in acute hyponatremia, accompanied by reduced claudin-5 and occludin expression and upregulation of IL-1β, IL-6, and iNOS gene expression; nevertheless, BBB leakage was absent in every group, and plasma nitrite was unchanged. None of these changes occurred chronically. Conversely, dihydroethidium staining showed increased arteriolar superoxide in all hyponatremic groups irrespective of duration. Similarly eNOS expression was elevated in both acute and chronic hyponatremia. Plasma nitrite was reduced only in chronic hyponatremia.
Conclusions: Edema in acute hyponatremia coincides with tight-junction downregulation and iNOS-driven vascular inflammation without measurable barrier leakage, indicating coexisting cytotoxic and vasogenic components and a peroxynitrite-favoring milieu. Oxidative stress with elevated eNOS expression is intrinsic to hyponatremia itself and, in the chronic phase, accompanies reduced NO bioavailability—a plausible microvascular substrate for cognitive impairment without edema.
Funding: This study was supported by the grant 2021/43/D/NZ4/03304 from National Science Centre, Poland.
